|
JOBS | TENDERS | DATING |
|
|
THE SMART NEWS SOURCE | Feb 11 2012 01:58 | LAST UPDATED Feb 11 2012 01:58 |
|
The South African Medical Association (Sama) is "gravely concerned" about HIV/Aids statistics, which show a huge Aids-related leap in South Africa's death rate. "We have always been concerned on whether it is correct to wait with treatment until a person's CD4 count has dropped to 200 [cells per microlitre]. We believe it might contribute to a higher mortality rate by delaying treatment," Sama chairperson Norman Mabasa said in a statement on Wednesday. The CD4 count is used to measure the strength of a person's immune system. Health Minister Aaron Motsoaledi said on Tuesday that in the 11 years from 1997 to 2008, the rate of death doubled in South Africa. In 2007, the total number of deaths -- from all causes -- registered in South Africa was 573 408; in 2008 this figure had leapt to 756 062. Motsoaledi pinned the blame for the current scale of the pandemic squarely on the denialist health policies pursued by former president Thabo Mbeki's government. Mabasa said the treatment threshold of 200 should be lifted to a CD4 count of between 300 and 350, which would be in line with global trends. "This must apply to both public and private sector, as HIV/Aids does not discriminate. We are cognisant that this step will result in more people requiring treatment and thus there would be financial implications, and government must be committed to it." -- Sapa  CONTINUES BELOW TOPICS IN THIS ARTICLE
comment guidelines
|
Client Media Releases
IN THIS WEEK'S PAPER
SUBSCRIBE: - Paper edition - iPad edition (NEW!) - Kindle edition - Digital edition Read stories online  @mailandguardian - Top stories & newsflashes @NicDawes - M&G editor Nic Dawes @ChrisRoperZA - Editor, M&G Online @amabhungane - M&G Centre for Investigative Journ @mgfeed - Our whole news feed Advertisements |
Contact Us | About Us | Story Tip-offs | Social media policy | Online Advertising | Print Advertising | Subscriptions | Topics A-Z | Mobile Sites | Privacy Policy | RSS Feed
All material © Mail & Guardian Online. Material may not be published or reproduced in any form without prior written permission.
 |
 |